Carrie Hall, MD
Dermatology · Hilton Head Island, SCNPI 1467478974
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,644 of the $14,703 with a category attached, or 86.0%. AbbVie accounts for 95.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $11,379 and has fallen 98.9% since, to $127 in 2025.
Across 55 payments — averaging $267.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- UCB, Inc.$175
- Pfizer$163
- Lilly USA, LLC$100
- LEO Pharma Inc.$81
- Organogenesis Inc.$66
- plus $96 from 6 others
What the payments were for
- Speaking & faculty fees$12,64486%
- Travel & lodging$5784%
- Food & beverage$1,45310%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $14,022 |
| UCB, Inc. | 4 | $175 |
| Pfizer | 2 | $163 |
| Lilly USA, LLC | 3 | $100 |
| LEO Pharma Inc. | 2 | $81 |
| Organogenesis Inc. | 4 | $66 |
| Prugen, Inc. Pharmaceuticals | 4 | $22 |
| Bristol Myers Squibb | 1 | $18 |
| Abbott | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Lupin Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,703 in reported general payments places this provider in the 85th percentile of 203 dermatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 13 | $91,019 |
| OtezlaApremilast | 14 | $78,959 |
| Fluorouracil | 56 | $2,971 |
| Clobetasol Propionate | 81 | $2,109 |
| Hydroxychloroquine Sulfate | 20 | $1,264 |
| Ketoconazole | 78 | $1,140 |
| Tacrolimus | 17 | $907 |
| Doxycycline Hyclate | 37 | $729 |
| Triamcinolone Acetonide | 116 | $724 |
| Nystatin | 35 | $576 |
| Betamethasone Dipropionate | 15 | $498 |
| ValacyclovirValacyclovir Hcl | 27 | $361 |
| Imiquimod | 13 | $273 |
| Mupirocin | 13 | $58 |
| Prednisone | 16 | $57 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hilton Head Island
- Marshall ShulerGreenville$2.6M
- Rebecca SmithFort Mill$2.3M
- Todd SchlesingerCharleston$1.9M
- Amylynne FrankelSpartanburg$987K
- Marguerite GermainMt Pleasant$200K
- George KeoughPawleys Island$150K
- Christopher MartinAbbeville$129K
- Lee CarsonGreenville$127K
- Mark SiegelCharleston$120K
- Jeffrey SmithWest Columbia$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.